Scholarship deadlines precede meetings by four months, abstract deadlines by three months and discounted
registration deadlines by two months. View details for each conference at http://www.keystonesymposia.org followed
by /19 and the alpha-numeric program code (e.g., http://www.keystonesymposia/19A1)..) Registered attendees of one
meeting in a joint pair may attend sessions of the other at no additional cost, pending space availability, and can take
advantage of the joint poster sessions and social breaks. iGlobal Health Series conference.
Drivers of Type 2 Diabetes: From Genes to Environment (S1) Seoul | South Korea
Framing the Response to Emerging Virus Infections (S2) Pok Fu Lam | Hong Kong
21st-Century Drug Discovery and Development For Global Health (S3)iBerlin | Germany
From Rare to Care: Discovery, Modeling and Translation of Rare Diseases (S4) Vienna | Austria
Leveraging Genomic Diversity to Promote Animal and Human Health (S5)iKampala | Uganda
Role of the Genital Tract Microbiome in Sexual and Reproductive Health (S6)iCape Town, Western Cape | South Africa
DNA Replication and Genome Instability: From Mechanism to Disease (A1) Snowbird, Utah | USA
Host and the Environment in IBD: Scientific Advances Leading to New Therapeutics (A2) Taos, New Mexico | USA
Mitochondrial Biology in Heart and Skeletal Muscle (J1)
joint with Mitochondria in Aging and Age-Related Disease (J2) Keystone, Colorado | USA
Single Cell Biology (L1) Breckenridge, Colorado | USA
Tuberculosis: Mechanisms, Pathogenesis and Treatment (A3) Banff, Alberta | Canada
Integrated Pathways of Disease in NASH and NAFLD (A4) Santa Fe, New Mexico | USA
Cancer Vaccines (L2) Vancouver, British Columbia | Canada
Digital Health: From Science to Application (A5) Keystone, Colorado | USA
Windows on the Brain: Formation and Function of Synapses and Circuits and Disruption in Disease (A6) Taos, New Mexico | USA
Cellular Plasticity: Reprogramming, Regeneration and Metaplasia (J3)
joint with Signal Dynamics and Signal Integration in Development and Disease (J4) Keystone, Colorado | USA
Transcription and RNA Regulation in Inflammation and Immunity (B1) Tahoe City, California | USA
Molecular Approaches to Vaccines and Immune Monitoring (J5) joint with B Cell–T Cell Interactions (J6) Keystone, Colorado | USA
Obesity and Adipose Tissue Biology (J7) joint with Functional Neurocircuitry of Feeding and Feeding Behavior (J8) Banff, Alberta | Canada
Autophagy: From Model Systems to Therapeutic Opportunities (B2) Santa Fe, New Mexico | USA
Uncovering Mechanisms of Immune-Based Therapy in Cancer and Autoimmunity (B3) Breckenridge, Colorado | USA
Genome Engineering: From Mechanisms to Therapies (B4) Victoria, British Columbia | Canada
Tumor Metabolism (B5) Keystone, Colorado | USA
Cell Competition in Development and Disease (B6) Tahoe City, California | USA
Myeloid Cells (B7) Santa Fe, New Mexico | USA
RNA-Protein Interactions (X1)
joint with Long Noncoding RNAs: From Molecular Mechanism to Functional Genetics (X2) Whistler, British Columbia | Canada
Phenotypic Drug Discovery: Recent Advances and Insights from Chemical and Systems Biology (C1) Breckenridge, Colorado | USA
Diabetes: Innovations, Outcomes and Personalized Therapies (X3)
joint with Unraveling the Secrets of Kidney Disease (X4) Whistler, British Columbia | Canada
Cancer Immunotherapy: Mechanistic Insights to Improve Clinical Benefit (C2) Whistler, British Columbia | Canada
Microbiome: Chemical Mechanisms and Biological Consequences (C3) Montréal, Québec | Canada
Innate Immune Receptors: Roles in Immunology and Beyond (M1) Taipei | Taiwan
Mammalian Sensory Systems (C4) Seattle, Washington | USA
Cancer Metastasis: The Role of Metabolism, Immunity and the Microenvironment (M2) Florence | Italy
Epigenetics and Human Disease (X5) joint with 3D Genome: Gene Regulation and Disease (X6) Banff, Alberta | Canada
Origins of Allergic Disease: Microbial, Epithelial and Immune Interactions (M3) Tahoe City, California | USA
Innate and Non-Classical Immune Cells in Cancer Immunotherapy (C5) Keystone Resort | Keystone, Colorado | USA
HIV Vaccines (X7)ijoint with Functional Cures and the Eradication of HIV (X8)i Whistler, British Columbia | Canada
Lipidomics and Functional Metabolic Pathways in Disease (C6) Steamboat Grand | Steamboat Springs, Colorado | USA
Imaging Across Scales: Leveraging the Revolution in Resolution (D1) Snowbird, Utah | USA
Protein Replacement through Nucleic Acid Therapies (R5) Steamboat Springs, Colorado | USA
Antibodies as Drugs: New Horizons in the Therapeutic Use of Engineered Antibodies (D2) Breckenridge, Colorado | USA
Proteomics and its Application to Translational and Precision Medicine (D3) Stockholm | Sweden
Skin Health and Disease: Immune, Epithelial and Microbiome Crosstalk (D4) Hannover | Germany
Biomolecular Condensates: Phase-Separated Organizers of Cellular Biochemistry (D5) Snowbird, Utah | USA
Immunometabolism, Metaflammation and Metabolic Disorders (D6) Vancouver, British Columbia | Canada
Small Regulatory RNAs (D7) Daejeon | South Korea
Delivering Therapeutics Across Biological Barriers (E1) Dublin | Ireland
Climate Change-Linked Stress Tolerance in Plants (M4) Hannover | Germany
Positive-Strand RNA Viruses (E2)iKillarney, County Kerry | Ireland
Neural Environment in Disease: Glial Responses and Neuroinflammation (Z1)
joint with Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2) Keystone, Colorado | USAhttp://www.keystonesymposia.org/meetings7–11
14–18
17–20
11–14
25–29
11–15
13–17
13–17
13–1713–17
17–21
20–24
20–24
21–25
21–25
27–312–5
10–14
10–14
17–21
18–22
19–23
24–28
24–28
24–28
24–283–7
3–710–14
10–14
10–14
15–19
15–19
17–21
24–27
24–28
24–28
31–4
7–10
7–10
7–11
7–11
8–11
10–13
14–18
14–18
6–9
13–16
9–13
16–20OctoberNovemberDecember
JanuaryFebruaryMarchAprilMayJunethe 2018–2019
Keystone
Symposia
Series